Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Indrayani Biotech Ltd (NSE: INDRANIB), ISIN INE007C01021 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
INDRANIB last traded at ₹9.07 (-3.51%), with a 52-week range of ₹6.10 to ₹16.47 (as of 23 Sep 2026).
Shareholding as of Dec 2025: promoters 33.26%, FIIs 0.00%, DIIs 3.13%, mutual funds 0.00%.
EquiSense Score (ECS): 18/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.